»ÆÉ«Ö±²¥

The Weston Brain Institute is delighted to launch ourÌýCanada:ÌýALS 2016Ìýprogram to support translational research of outstanding scientific merit that will accelerate the development of safe and effective therapeutics for amyotrophic lateral sclerosis (ALS).

Program Information Session

Tuesday, March 22^nd, 2:00pm EDT

Letter of Intent deadline

Tuesday, April 19^th, 2:00pm EDT

Visit our website forÌý

Funding & Eligibility

Applicants may apply toÌýbothÌýthe Canada: ALS 2016 Rapid Response program and Canada: ALS 2016 Transformational Research program.

Canada: ALS 2016 Rapid Response

Canada: ALS 2016 Transformational Research

· Seed funding for novel, high-risk, high-reward research

· Up toÌý$150,000ÌýandÌý18 monthsÌýper project

· Preliminary data is optional

· Principal Applicants must be at the level of Postdoctoral Fellow or higher

· Applicants can only appear once as either the Principal Applicant or the Administrative Supervisor

· Larger, longer grants that significantly advance preclinical research

· Up toÌýÌý$1.5 millionÌýandÌý3 yearsÌýper project

· Must have excellent preliminary data

· Principal Applicants must be at the level of Assistant Professor or higher

See theÌýÌýand theÌýÌýfor more information.

Program Information Session

The Weston Brain Institute will be holding an online Information Session onÌýTuesday, March 22^ndat 2:00pm EDTÌýto provide you with comprehensive information on the application process and an opportunity for open questions. ÌýÌý

The Institute welcomes inquiries about our funding programs atÌýneuro@weston.caÌýor 416-935-4056.

Weston Brain Institute